Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 6, 1997
Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
B M Pützer, M Hitt, W J Muller, et al.
Gene Therapy
|
January 13, 1998
Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha
R A Marr, C L Addison, D Snider, et al.
Human Gene Therapy
|
October 20, 1996
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
J L Bramson, M Hitt, C L Addison, et al.
The American Journal of Pathology
|
December 7, 2000
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression
M E Kupferman, M E Fini, W J Muller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1992
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
C T Guy, M A Webster, M Schaller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 20, 1996
Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target
J L Jakubczak, G Merlino, J E French, et al.
Gene Therapy
|
February 4, 1999
Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
C L Addison, J L Bramson, M M Hitt, et al.
Human Gene Therapy
|
April 21, 1999
Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models
P C Emtage, Y Wan, M Hitt, et al.
Oncogene
|
October 20, 1998
Active signaling by Neu in transgenic mice
M P DiGiovanna, M A Lerman, R J Coffey, et al.
Molecular and Cellular Biology
|
November 1, 1985
Sequence-dependent DNA replication in preimplantation mouse embryos
D O Wirak, L E Chalifour, P M Wassarman, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
Proceedings of the National Academy of Sciences of the United States of America
|
October 6, 1997
Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
B M Pützer, M Hitt, W J Muller, et al.
Gene Therapy
|
January 13, 1998
Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha
R A Marr, C L Addison, D Snider, et al.
Human Gene Therapy
|
October 20, 1996
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
J L Bramson, M Hitt, C L Addison, et al.
The American Journal of Pathology
|
December 7, 2000
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression
M E Kupferman, M E Fini, W J Muller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1992
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
C T Guy, M A Webster, M Schaller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 20, 1996
Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target
J L Jakubczak, G Merlino, J E French, et al.
Gene Therapy
|
February 4, 1999
Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
C L Addison, J L Bramson, M M Hitt, et al.
Human Gene Therapy
|
April 21, 1999
Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models
P C Emtage, Y Wan, M Hitt, et al.
Oncogene
|
October 20, 1998
Active signaling by Neu in transgenic mice
M P DiGiovanna, M A Lerman, R J Coffey, et al.
Molecular and Cellular Biology
|
November 1, 1985
Sequence-dependent DNA replication in preimplantation mouse embryos
D O Wirak, L E Chalifour, P M Wassarman, et al.
Page
of 12